Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,380,532
+$1,195,140 QoQ
Shares Held
102,186
+586.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Jun 30, 2022CallValue
$2,094,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
154,970 | $4,667,696 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
188,802 | $4,659,633 | |
| 3 | CRON |
Cronos Group Inc.
|
1,500,000 | $3,765,000 | |
| 4 | LQDA |
Liquidia Corp
|
40,595 | $1,532,055 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,345 | $1,390,538 | |
| 6 | VTRS |
Viatris Inc
This page
|
102,186 | $1,380,532 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
50,735 | $1,146,611 | |
| 8 | ALKS |
Alkermes plc.
|
16,928 | $598,574 |
All Filings in VTRS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,380,532 | 102,186 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $185,392 | 14,891 | Shares | Other | 2026-02-17 | |
| 2025-03-31 | $2,579,414 | 296,144 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $3,581,616 | 287,680 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,166,712 | 358,890 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $3,974,471 | 373,892 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $3,308,251 | 277,073 | Shares | Other | 2024-05-15 | |
| 2022-09-30 | $162,953 | 19,126 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,094,000 | 200,000 | Call | Other | 2022-08-24 | |
| 2022-03-31 | $2,176,000 | 200,000 | Call | Other | 2022-05-16 | |
| 2021-12-31 | $2,036,265 | 150,500 | Call | Other | 2022-02-14 | |
| 2021-09-30 | $2,036,565 | 150,300 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $2,147,787 | 150,300 | Call | Sole | 2021-08-16 | |
| 2020-12-31 | $1,158,132 | 61,800 | Call | Other | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||